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Summary
We presented and discussed one interesting medical prescription by doctor Giuseppe 
Moscati (1880-1927), who prescribed magnesium oxide (magnesia usta) to a patient with 
the diagnosis of “neuralgia of the celiac plexus of rheumatic origin”. Besides the traditional 
use of magnesium as antacid remedy at the time, we raised the hypothesis that magnesium 
could be administered by Moscati in order to treat the neuralgia itself. Considering the sci-
entific background of Moscati at the school of Filippo Bottazzi (1867-1941), a father of Italian 
biochemistry, we suggested that the doctor tried to apply the preliminary concepts acquired 
from electrophysiological studies on magnesium to his clinical practice. Only after decades, 
magnesium was recognized a fundamental ion in the energy metabolism and in contributing 
to maintain the ionic intracellular homeostasis, including for neurons.
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Introduction
Magnesium plays a critical role in a number of physiological processes, 
including the modulation of nociception by means of the antagonistic action 
on the N-methyl-d-aspartate (NMDA) receptors (1, 2). Indeed, this scientific 
acquisition resulted from researches carried on in the last decade of the 20th 
century (3). Nowadays, magnesium sulphate is considered a useful adjuvant 
in obstetric anaesthesia and intensive care thanks to its favourable effect in 
reducing analgesic therapy or prolonging the duration of anaesthesia (4); 
nonetheless, in any case magnesium is considered useful in the treatment of 
chronic painful disorders, such as migraine (5) and fibromyalgia (6).
 In the present article, we aimed to discuss one interesting document by 
Giuseppe Moscati (1880-1927), who prescribed magnesium to a patient af-
fected by celiac plexus nerve pain (Fig 1). Giuseppe Moscati was an eminent 
physician of the first part of the 20th century, medical doctor and professor 
at the University of Naples (7-9).
Fig. 1. Giuseppe Moscati’s prescription for a patient with “neuralgia (del 
plesso celiaco) d’origine reumatica (ci furono artro-sinoviti reumatiche); fegato 
leggermente congesto”, that is “neuralgia (of the celiac plexus) of rheumatic 
origin (there were rheumatic arthro-synovites); mild liver congestion”. 
Dated 28 March 1923.
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Moscati’s prescription of magnesium for a patient with chronic pain is very 
intriguing, because it points to the concept that ions play a role in the patho-
genesis of neural disorders. In this light, magnesium might be prescribed in 
order to modulate the pain, besides its traditional use an antacid. To the best 
of our knowledge, no other coeval documents show the magnesium oxide 
prescription for pain management. During the first decades of the 20th cen-
tury, it was recognized that many pathological conditions were correlated to 
Mg deficiency. However, since the uptake and the release of Mg depend on 
many factors, the mechanisms of its intracellular homeostasis were almost 
unknown. In the following years, it was ascertained that Mg has a critical 
role in the energy metabolism and in maintaining the ionic intracellular ho-
meostasis in association with potassium and calcium by a mechanisms of in-
take or release requiring energy (ATP). The molecular mechanisms of these 
functions were investigated and progressively resolved in the second half of 
the 20th century. Keynes, working with the great neurophysiologist Hodgkin 
AL, carried out experiments with radioactive tracers to follow movements 
of ions (10). In 1957, Skou demonstrated that the transport of sodium and 
potassium in-and-out the intracellular milieu through the cellular plasma 
membrane requires energy supplied by a membrane ATPase (11). The mech-
anism of Mg in muscle contraction/relaxation cycle was revealed in 1961 by 
the experiments on isolated sarcoplasmic reticulum fragments carried out 
by Muscatello (12-14) and the critical role of calcium pump by sarcoplasmic 
reticulum was shown by Weber AM in the same years (15, 16).
Moscati’s prescription
We present Moscati’s medical prescription (Fig. 1), housed in the muse-
um dedicated to doctor, next to the Chiesa del Gesù Nuovo in Naples. The 
museum keeps more than 300 Moscati’s medical documents, which have also 
been digitally recorded.
The present document, dated 28 March 1923, shows an unknown pa-
tient’s diagnosis of ‘neuralgia of the celiac plexus of rheumatic origin’. Any other 
information regarding this patient, such as age or gender, is unavailable. The 
prescribed therapy consists of a few remedies, well separated by a horizon-
tal stretch of the pen: 1. iodine tincture diluted in olive oil, with an increas-
ing-decreasing dosages schedule, preceded by a small amount of castor oil; 
2. magnesia usta (magnesium oxide, MgO); 3. sulphur hypodermic injections 
(preferably a colloidal sulphur drug produced by the Dausse manufacturer).
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Moscati’s prescription seems to follow a logical pattern starting from the 
patient’s symptoms and ending in the hypothesized etiology of the disease.
The first remedy would suggest the resetting of the gastrointestinal func-
tion with a known irritating drug, able to induce hyperthyroidism, classi-
cally administered orally for tubercular lymphadenitis (‘scrofula’), goitre, 
secondary form of syphilis, but also for nervous non-inflammatory diseases, 
particularly gastric neuralgias (17). The iodine therapy was preceded by a tea-
spoon of castor oil, as an associated remedy, probably in order to accelerate 
the intestinal transit of the primary drug that was known to be toxic; the 100 
drops contained up to 300 mg of iodine (18). Moreover, Moscati’s awareness 
of this toxicity is evidenced by the increasing-decreasing schedule of admin-
istration and because it was explicitly indicated to the patient with the ’N.B.’ 
(Latin abbreviation for ‘nota bene’, note well) comment.
The second treatment consists of a very small amount (a teaspoon tip) 
of MgO, taken 2 hours after meals. The traditional use of a small quantity 
of this medical powder was as an antacid treatment, and its administration 
timing may support this rational of use. Moreover, this lenitive purpose may 
be suggested by the previous administration of an irritating drug. However, a 
second interpretation could be suggested: MgO could have been prescribed 
to directly counteract the neuralgia, as a ‘pathogenetic’ treatment.
Lastly, the third prescription points to treat the presumed cause of the 
neuralgia, which is ‘rheumatism’. This ‘etiologic’ therapy consists in paren-
teral administration of sulphur, according to the knowledge of the time (19, 
20). To note, Moscati indicated to the patient that sulphur injections were 
very painful, so the colloidal product by Dausse was preferable.
Discussion
Moscati’s prescription shows a diagnosis of neuralgia of the celiac plexus 
of rheumatic origin. No patient’s information is given, with the exception 
of a mild liver congestion. We may presume that it was the case of an adult 
subject on the basis of the high dose of iodine tincture prescribed. The di-
agnosis of neuralgia was not a novelty, since the anatomy and the physiology 
of the celiac plexus were well known, as well as the possibility of painful 
syndromes of the abdominal organs innervated by the plexus (21). With the 
term ‘celiac neuralgia’ a disorder was diagnosed characterized by sponta-
neous paroxysmal recurrent pain in the epigastric region, without dyspepsia 
and other digestive disturbances; the pain is sudden and may disappear after 
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a few minutes, and the pressure at the epigastrium alleviates the symptom; 
finally, the pain is associated with a feeling of extreme faintness and anxiety, 
as well as in angina pectoris (22). Indeed, this non-organic disorder was at-
tributed to the young-middle aged people, much more frequently in women, 
frequently connected with hysteria; the actual etiology was unknown (22). 
Given the very scarce diagnostic possibility of the time, the ‘celiac neuralgia’ 
could be attributed to several diseases; however, the exclusion of an organ-
ic etiology and the association with the anxious disorders assists in the hy-
pothesis of a psychosomatic disease, i.e. fibromyalgia. Moreover, neuralgias 
were recognized as a consequence of several endogenous intoxications, i.e. 
of rheumatic origin (23). The treatment of neuralgia included several symp-
tomatic remedies, such as arnica, calendula, artemisia, valeriana, opium, 
belladonna, nux vomica, strychnia, sugar, carbon, bismuth, arsenic, citrate 
of iron, and iodine (22); the latter was indicated for chronic neuralgia, in ad-
dition to analgesics (23).
All the remedies from the Moscati’s prescription discussed in this article 
were well known and used by doctors in the same period; indeed, these treat-
ments may be easily considered within the clinical use of the time, on the 
basis of the concepts obtained from the contemporary literature (17-20, 23). 
However, with regards to MgO, an interesting hypothesis regarding the ra-
tional of use could be raised. The prescription of magnesium salts by Moscati 
was frequently found in the corpus of more than 300 medical prescriptions 
preserved in the museum of the Chiesa del Gesù Nuovo, Naples. However, 
while the magnesium citrate was often prescribed for purgative purpose 
(generally explicitly indicated by Moscati), only 2 documents, including the 
present, reported ‘magnesia usta’ for 2 patients affected by painful epigastric 
disorders.
The Italian term “magnesia usta” indicated a galenic preparation of MgO, 
obtained from magnesium carbonate kept in a red heat for 2 hours (calcina-
tion). MgO, which looks like bulky white powder, was used as a purgative 
treatment from as early as the 18th century (24). Moreover, MgO was con-
sidered a valid treatment for dyspepsia and acidity, and it was preferable to 
magnesium carbonate, because the neutralization of the acid of the stomach 
was obtained without any production of gas (25, 26). Differently, the other 
authors attributed to MgO the ability to reduce the intestinal irritability in 
patients with diarrhoea (27). Again, MgO was indicated as a valuable reme-
dy against some poisons (such as phosphorus, arsenic or acids) or the pro-
duction of renal uric acid deposits (17); indeed, the name “magnesium” itself 
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derives from the Latin “magnes” (magnet), stressing the property of Mg salts 
to attract the ‘bad humors’ in the body, as supposed universal medical rem-
edy. In order to achieve the antacid effect whilst avoiding the laxative prop-
erties, the physician could moderate the dose of dispensed MgO, preventing 
further discomfort for the patients (17).
Besides the traditional use of ‘magnesia usta’, Moscati might have pre-
scribed MgO to treat the neuralgic pain. In other words, it was possible that 
the professor used MgO as a specific remedy against neuralgia. This hypoth-
esis can be verified by means of the evaluation of the other Moscati’s doc-
uments. In fact, differently from several other prescriptions of magnesium 
citrate (sometimes named ‘magnesia purgativa’) which was prescribed in or-
der to achieve a faster intestinal transit, MgO was used in only 2 cases of 
epigastralgia, namely our case of “celiac neuralgia” and another case of pain-
ful “gastric erosion”. Therefore, the prescription of MgO could be explained 
with the aim to alleviate patient’s gastric discomfort. Secondly, MgO, pre-
scribed 2 hours after meals, was traditionally used as an antacid treatment. 
However, the diagnosis of celiac neuralgia indicated a non-organic disorder 
of the stomach, which did not require antacids. Moreover, in the other case 
of “gastric erosion”, the prescription of MgO was associated with bismuth 
carbonate, which was largely employed as remedy for dyspepsia in the 20th 
century (28). Thus, it was possible that Moscati used MgO to treat the pain 
itself, which was primitive, neuropathic in the first case and consequent to 
gastric erosion in the second one. This hypothesis is also supported by the 
lack of prescription of typical analgesic drugs that were widely used at the 
time (22).
In the first decades of the 20th century, there was no medical knowl-
edge which indicated the use of MgO as a therapy against celiac neuralgia, 
therefore Moscati used magnesia usta in this neuropathic disorder probably 
on the basis of personal observations. Interestingly, the effect of the mag-
nesium in the physiologic electrical processes of the muscular cells was 
studied by several European physiologists at the Moscati’s time, including 
also the Bottazzi’s school, which Moscati belonged to (29). In fact, several 
researchers described the curare-like effect of magnesium on muscle tissue 
(30). Moreover, previous observations had suggested the use of MgO as an 
antispastic therapy (27). Therefore, it was plausible that Moscati applied to 
his clinical practice the new knowledge coming from the novel scientific 
discipline named “ physic chemistry ” (biochemistry), consistently with the 
current concepts of translational medicine.
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Nowadays, the therapeutic role of magnesium has considerably expand-
ed, thanks to the discovery of its importance in the electrophysiological 
processes of the muscular and neuronal cells (31, 32). Indeed, Mg cations 
regulate, via the Ca/Mg ratio, the release of all the neurotransmitters, the 
opening of NMDA-glutamate receptors, the smooth muscle cells tone, and 
the contraction-relaxation cycles of all types of muscle cells, acting as Ca 
antagonists (30). The myocardial membrane sodium gradient is maintained 
by a Mg-dependent Na-K-ADPase (34), and increasing extra/intracellular 
Mg concentration inhibit T- and L-type Ca channels (35). Consequently, 
infusion of Mg resulted in prolonged atrioventricular node conduction, PR 
or QRS durations, and the prolongation of the atrial and ventricular refrac-
tory periods (36). In pregnancy, oral Mg supplementation is used to reduce 
the risk of preterm birth (37). Another field of employment for Mg is rheu-
matology, with regards to the chronic management of patients affected by 
fibromyalgia (FM), a rheumatic non-inflammatory disease characterized by 
chronic widespread pain, diffuse hyperalgesia, muscle spasms, fatigue, ir-
ritable bowel syndrome, sleep disorders, cognitive and mood disturbances. 
Etiologically, the strongest evidence points to the alteration of pain modu-
lation in the central nervous system; nonetheless, peripheral abnormalities 
such as local hypoxia may facilitate peripheral nerve sensitization (38, 39). 
Secondly, deregulation in the sympathetic autonomic and hypothalamic–pi-
tuitary–adrenal systems was also described in FM (40). The rationale of use 
is the relative decrease of Mg levels in FM patients, namely in muscle cells 
or erythrocytes (41-43); moreover, a daily oral Mg supplementation improves 
FM symptoms (41, 44). In light of recent knowledge on the central nervous 
origin of pain associated with fibromyalgia, Mg supplementation may be 
considered useful to inhibit the development of neuropathic pain, thanks to 
its antagonist action on NMDA receptors, which are important in the pro-
cess of central sensitization (2).
In conclusion, our analysis of Moscati’s medical prescription suggests the 
high scientific value of the doctor, who formulated a diagnosis that shows 
his attention to a correct definition of a patient’s clinical status, with a view 
to its etiopathogenesis, despite the scarcity of diagnostic instruments of the 
time. The text of this medical prescription also supports the piety of Moscati 
(in 1987, the pope Johannes Paulus II canonized G. Moscati, “the physician 
of the poor”, into a catholic church saint), who did not bother to inform the 
patient about the probable adverse effects of the therapy prescribed, and at 
the same time gave indications on how to deal with these problems. Last but 
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not least, we suggested that Moscati’s prescription of MgO might hide a new 
rational of use of this traditional remedy against the painful neuropathic 
syndromes. 
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Sažetak
Prikazali smo i razmotrili zanimljivu medicinsku terapiju doktora Giuseppea Moscatija 
(1880. – 1927.) koji je propisao magnezijev oksid (magnesia usta) pacijentu s dijagnozom 
“neuralgije celijačnog pleksusa reumatoidnog podrijetla”. Osim tradicionalne upotrebe ma-
gnezija kao antacidnog lijeka u to doba, pretpostavili smo da je Moscati propisao magnezij 
kako bi liječio samu neuralgiju. S obzirom na znanstvenu pozadinu Moscatija u školi Filippa 
Bottazzija (1867. – 1941.), oca talijanske biokemije, sugerirali smo da je liječnik pokušao pri-
mijeniti preliminarne koncepte dobivene iz elektrofizioloških istraživanja na magneziju u 
svoju kliničku praksu. Tek nakon nekoliko desetljeća magnezij je prepoznat kao temeljni ion 
u energetskom metabolizmu koji pridonosi održavanju ionske intracelularne homeostaze, 
uključujući i neurona.
Ključne riječi: Giuseppe Moscati, Filippo Bottazzi, magnezijev oksid, magnesia usta, 
neuralgija, cilijanični pleksus
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